*Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality.
In particular, glycaemic control is considered a key target of treatments for T2D patients, with high glycated haemoglobin (HbA1c) levels associated with disease progression [12]
doi: 10.1016/0306-9877(92)90081-M 15 KaganVEMaoGQuFAngeliJPDollSCroixCSet al
Quick Stats for L-carnitine Supplements Market L-Carnitine Supplements Market Value (2025): USD 242.7 million L-Carnitine Supplements Market Forecast Value (2035): USD 434.6 million L-Carnitine Supplements Market Forecast CAGR: 6% Leading Segment in L-Carnitine Supplements Market in 2025: Food Grade (55% market share) Key Growth Regions in L-Carnitine Supplements Market: North America, Western Europe, East Asia Top Key Players in L-Carnitine Supplements Market: Lonza Group Ltd., Northeast Pharmaceutical Group Co., Ltd., Ceva Sant Animale S.A., KaiyuanHengtai Chemical Co., Ltd., ChengDa Pharmaceuticals Co., Ltd
